Background: This study was aimed at investigating the role and molecular mechanism of Sam68 in cervical cancer lymph node metastasis.
introduction
Cervical cancer remains the second most frequent cancer among women across the world, with an estimated 493 243 new cases and 273 505 deaths from the disease in the year 2002 [1] . Cervical cancer is much more common in the developing countries, where 83% of cases occur [1] . Although the status of the retroperitoneal lymph nodes is not included in the International Federation of Gynecology and Obstetrics (FIGO) staging system, lymph node metastasis is the strongest prognostic factor for early stage cervical cancer (FIGO stage Ib-IIa) and provides important information for determining the treatment approach [2] . However, thus far, no sufficiently accurate model to predict lymph node metastasis preoperatively has been established, and the molecular mechanism underlying cervical cancer metastasis remains to be elucidated.
Sam68 (Src associated in mitosis 68 kDa) belongs to the signal transducer and activator of RNA (STAR) family of RNA-binding proteins that link signaling pathways to RNA processing [3] . Sam68 play a major role in the regulation of RNA metabolism through RNA processing and export [4] . Furthermore, alternative splicing of multiple genes, including CD44, Bcl-xl, Sgce and Cyclin D1, has been reported to be regulated by Sam68 [5] [6] [7] [8] . Sam68 may also serve as an adaptor protein in signal transduction by interacting with a set of signaling proteins, such as Src, BRK, PI3K, FBP21 and FBP30, through its proline-rich motifs and their SH2, SH3 and WW domains [9] [10] [11] [12] [13] . A series of published reports stated that Sam68 expression was up-regulated in a variety of human cancers, including prostate cancer [14] , renal cell carcinoma [15] and breast cancer [14, 16] , indicating that Sam68 might act as a oncogene that promotes tumor progression, and as quite recently revealed, metastasis [17] . Moreover, Sam68-null mice have been reported to show uterine development defects [18] . In the light of these findings, we investigated the expression profile of Sam68 in cervical cancer and report here, for the first time, that Sam68 expression is correlated to pelvic lymph node metastasis as well as prognosis in patients with early-stage cervical cancer, and Sam68 might induce cervical cancer lymph node metastasis through regulating epithelialmesenchymal transition (EMT) by Akt/GSK-3b/Snail pathway.
materials and methods

samples and patients
In the current retrospective study, 306 patients with early-stage cervical cancer who received radical hysterectomy and lymphadenectomy in the Department of Gynecologic Oncology (Cancer Center, Sun Yat-sen University, Guangzhou, China) from January 1999 to December 2004 were enrolled. Twenty samples of chronic cervicitis from patients underwent simple hysterectomy because of hysteromyoma were obtained as controls. Twelve fresh cervical cancer and paired adjacent noncancerous cervical tissues were collected for quantitative polymerase chain reaction (qPCR) and western blotting analysis. All the paraffinembedded tissues and fresh tissues were taken with the consent from each patient.
This study was approved by the medical ethics committee of Cancer Center, Sun Yat-Sen University. Clinical/pathological features of the cervical cancer cohort are outlined in Table 1 . All the patients were followed up on regular basis and the last follow-up was carried out in May 2010, with the mean observation period of 73 months (1-124 months) and 33 cancer-related deaths. All 51 patients who were detected with lymph node metastasis received adjuvant chemoradiation postoperatively.
cell lines, plasmids and antibodies
The cervical cancer cell lines HeLa, SiHa and C 33A were cultured in Eagle's minimum essential medium (GIBCO BRL, Rockville, MD) and Ca ski was cultured in RPMI-1640 medium (GIBCO BRL), all supplemented with 10% fetal bovine serum (HyClone Laboratories, Logan, UT). Two human short hairpin RNA (shRNA) sequences to repress Sam68 expression were cloned into the pSuper-retro-neo plasmid, respectively; the sequences are listed at supplemental Table S4 (available at Annals of Oncology online). Retroviral production and infection were performed as described previously [19] . Mouse anti-E-cadherin, anti-a-catenin, anti-fibronectin, anti-vimentin (BD Transduction Laboratories, Lexington, UK) and anti-glyceraldehyde-3-phosphate dehydrogenase (anti-GAPDH; Santa Cruz Biotechnology, Santa Cruz, CA) as well as rabbit anti-Sam68 (Santa Cruz Biotechnology), anti-p-GSK, anti-t-GSK, anti-p-Akt, anti-t-Akt (Cell Signaling Technology, Danvers, MA), anti-Snail (Abcam, Cambridge, UK) antibodies were used in this study. Fluorescein isothiocyanate-conjugated antibodies (Invitrogen, Carlsbad, CA) and DAPI (Sigma-Aldrich, St Louis, MO) were used in immunofluorescence analysis.
RNA extraction, reverse transcription and qPCR
Total RNA from cultured cells and fresh tissues were extracted using the Trizol reagent (Invitrogen) according to the manufacturer's instruction. About 2 lg RNA from each sample was used for cDNA synthesis with iScriptä cDNA Synthesis Kit (Bio-Rad Laboratories, Hercules, CA). qPCR was employed to quantify the fold change of Sam68 messenger RNA (mRNA) level by Bio-Rad CFX96 sequence detection system with SsoFast EvaGreen Supermix (Bio-Rad Laboratories). Expression data were normalized to the geometric mean by housekeeping gene GAPDH. The qPCR primers for Sam68 and GAPDH are listed in supplemental Table S4 (available at Annals of Oncology online). All genes were tested in triplicate. original article
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Immunohistochemistry staining was carried out using Histostain-Plus Kits (Invitrogen) following the manufacturer's protocols. Two independent pathologists blinded to the clinical parameters conducted the immunoreactivity score (IRS) for Sam68 expression. The staining results were scored based on the following criteria: (i) percentage of positive tumor cells in the tumor tissue: 0 (0%), 1 (1%-10%), 2 (11%-50%), 3 (51%-70%) and 4 (71%-100%); (ii) staining intensity: 0 (no signal), 1 (weak), 2 (moderate), 3 (strong). IRS was calculated by summing the score for the percentage of positive cells and the intensity score (range from 0 to 7) [20] . The final score ‡3 were considered high expression.
3D morphogenesis Matrigel culture, wound-healing and Boyden chamber invasion assay
Twenty-four well dishes were coated with growth factor-reduced Matrigel (BD Biosciences, San Jose, CA) and covered with growth medium supplemented with 2% Matrigel. Cells were seeded as 1· 10 4 cells/well, and the medium was replaced with 2% Matrigel for 3-4 days. Then, microscopic images were captured at 2-day intervals for 2 weeks. For wound-healing assay, cells were seeded at a density of 2 · 10 6 cells per 35-mm Petri dish. A wound was created using an aerosol P200 pipette tip after 12 h of incubation, then microscopic images were taken immediately (time 0 h) and thereafter at 8 and 16 hours. In the Boyden chamber invasion assay, 2 · 10 4 cells were seeded into 8-lm pore inserts that were coated with 50 lL Matrigel (BD Biosciences) in triplicate wells. After 24 h, the cells that passed through the filter into the lower chamber were then fixed with 1% paraformaldehyde, stained with hematoxylin and counted (10 random 100· fields per well).
statistical analysis
All statistical analyses were carried out with SPSS software package (IBM, standard version 18.0). The relationship between Sam68 expression and clinical-pathological characteristics was assessed using Pearson's v 2 test.
Survival curves were plotted by the Kaplan-Meier method and compared by the log-rank test. Multivariate survival analysis was carried out for all of the parameters that were significant in the univariate analysis using the Cox regression model. A two-sided probability value of <0.05 was considered statistically significant.
results elevated expression of Sam68 in cervical cancer
To investigate the potential role of Sam68 in the tumorigenesis of cervical cancer, western blotting, qPCR and immunohistochemistry assay were carried out in cervical cancer cell lines (Ca ski, C 33A, HeLa and SiHa), normal cervical tissues and fresh cervical cancer tissues (T) with paired adjacent noncancerous tissues (ANT). As shown in Figure 1A -C, both Sam68 protein and mRNA were highly expressed in the examined cervical cancer cell lines and specimens compared with that in normal cervical tissues and paired adjacent noncancerous tissues. Furthermore, the T/ ANT ratios for Sam68 mRNA expression level in the specimens with pelvic lymph node metastasis (2.4-20.9, metastatic, Figure 1B ) were higher than those in the specimens without pelvic lymph node metastasis (1.6-7.5, nonmetastatic). Then, we detected positive expression of Sam68 in 89.9% (275/306) of paraffin-embedded cervical cancer tissues. In contrast, Sam68 was marginally or not detectable in the normal cervical tissue or in areas surrounding the cancerous tissues in all tumor sections. As shown in Figure 2 , Sam68 immunostaining showed two main patterns: localization in the cytoplasm ( Figure  2A -H) and localization in the nucleus of tumor cells ( Figure 2I -P).
Sam68 expression and localization were associated with high-risk factors, especially pelvic lymph node metastasis The association between Sam68 expression level and clinicalpathological characteristics in early-stage cervical cancer patients was studied further. Significant correlation was observed between Sam68 expression level and several prognostic risk factors such as lymphovascular space involvement (LVSI, P = 0.012), positive parametrium (P = 0.031), and most importantly, lymph node metastasis (P < 0.001) ( Table 2) . Furthermore, squamous cell carcinoma antigen, known as an indicator of pelvic lymph node metastasis, was correlated with Sam68 expression level (P = 0.003) ( Table 2 ). Univariate and multivariate analysis showed that deep stromal invasion (P = 0.009) and Sam68 expression (P < 0.001) were independent factors that influenced pelvic lymph node metastasis. Interestingly, Sam68 protein subcellular localization (cytoplasmic versus nuclear) was significantly correlated with tumor size (cut-off 4 cm, P = 0.009), but not with other clinical/ pathological characteristics (supplemental Table S1 , available at Annals of Oncology online). The results of Spearman correlation analysis between Sam68 expression, subcellular localization, and Tables S2  and S3 (available at Annals of Oncology online).
Sam68 expression and cytoplasmic localization were predictors of poor survival
In our study cohort, both overall survival (OS) rate and diseasefree survival (DFS) rate of patients with high Sam68 expression level was significantly lower than that of patients with low Sam68 expression level (P < 0.001, respectively, log-rank test; Figure 3A and E). Furthermore, although no difference was observed in the DFS rate between patients of the cytoplasmic and nuclear groups (data not provided), the OS rate of patients with cytoplasmic Sam68 expression was significantly lower than that of patients with nuclear Sam68 expression (P = 0.031, log-rank test; Figure  3B ). When stratified on the basis of subcellular localization, both OS and DFS rate discrepancy in the cytoplasm group was greater than that observed in the entire cohort ( Figure 3D and F) , while the OS rate difference was weakened in the nuclear group ( Figure  3C ). Cox regression model revealed that only pelvic lymph node metastasis (relative risk: 4.116, CI 1.811-9.356, P < 0.001), Sam68 expression level (relative risk: 2.751, CI 1.070-7.074, P = 0.036), and subcellular localization (relative risk: 2.224, CI 1.091-4.535, P = 0.028) served as independent prognostic factors for poor OS.
down-regulation of Sam68 inhibited cellular motility and invasion
To further identify the role of Sam68 in the progression of cervical cancer, two short hairpin RNAs for Sam68 was employed to suppress endogenous Sam68 expression stably in HeLa and SiHa cell lines. As we expected, down-regulation of Sam68 reduced irregular branched structures of both cells in 3D morphogenesis Matrigel cultures, which characterized the invasive phonotype ( Figure 4A ). Moreover, wound-healing assay and Boyden chamber invasion assay both revealed that the motility and invasiveness of HeLa SiHa cells were dramatically hampered by the ablation of Sam68 ( Figure 4B and C).
down-regulation of Sam68 reversed EMT and inhibited Akt/GSK-3b/Snail pathway
Although no EMT-associated morphological changes were observed in Sam68 suppressed cells, knockdown of Sam68 inhibited the expression of mesenchymal markers such as vimentin and fibronectin but partially rescued the expression of epithelial markers including a-catenin as well as E-cadherin ( Figure 5A and B) . Furthermore, silencing endogenous Sam68 crippled the expression of phosphorylated Akt, but not total Akt, while the expression of Snail and phosphorylated GSK-3b, but not total GSK-3b, were also down-regulated ( Figure 5C ). Additionally, the transcriptional level of Snail was not affected by Sam68 suppression (data not shown), suggesting that the alteration of Snail expression might be due to posttranscriptional modification.
discussion
In this study, we showed, for the first time, that the expression of Sam68 was up-regulated in cervical cancer at both mRNA and protein levels in comparison with that in normal cervical tissues. High expression level of Sam68 and its cytoplasmic localization were significantly associated with tumor size, LVSI, positive parametrium, and most importantly, pelvic lymph node metastasis. High expression level of Sam68 and its cytoplasmic localization served as independent prognostic factors for short OS and DFS rate in patients with early-stage cervical cancer. Moreover, suppression of Sam68 repressed cellular motility and invasion, reversed EMT through inhibiting Akt/GSK-3b/Snail pathway. In the light of these findings, we considered that Sam68 has the potential to be a novel predictor of pelvic lymph node metastasis as well as a promising therapeutic target in cervical cancer patients. Thus far, radical hysterectomy plus lymphadenectomy or chemoradiation have remained the standard treatment of earlystage cervical cancer patients [21, 22] . For patients with lymph node metastasis, chemoradiation are required, which would make the initial surgical procedure unnecessary in retrospect [23] . However, unfortunately, no accurate and efficient techniques of diagnosing lymph node metastasis are available to help gynecologic oncologists direct choice of treatment, avoid unnecessary surgical intervention, and reduce morbidity. Imaging methods currently used to detect lymph node status may be inaccurate (in meta-analysis, pooled positive likelihood ratio of 15.3 for positron emission tomography, 6.4 for magnetic resonance imaging and 4.3 for computed original article Annals of Oncology tomography) [23] . Another promising technique, sentinel lymph node biopsy failed to show sufficiently accurate either in multicenter study [24] .
Our data showed that the expression level of Sam68 and its cytoplasmic localization were correlated significantly with known risk factors concerning recurrence and poor prognosis, especially pelvic lymph node metastasis. The accuracy of predicting pelvic lymph node metastasis by investigating Sam68 expression level (high versus low) in our cohort was 44% (45/ 102). However, in patients who demonstrated high expression of Sam68 but were not detected with lymph node metastasis, the recurrence rate reached 19.3%, whereas only 8.6% patients (P < 0.01) were detected with recurrence in the group of low expression of Sam68. Given that reported pelvic lymph node micrometastasis rate in early-stage cervical cancer patients was 15% [25, 26] , it is highly likely that the ''real'' accuracy of predicting pelvic lymph node metastasis by investigating Sam68 expression level (high versus low) could be 59% (44% plus 15%). To address that problem, further study extended to a larger cohort of patients of lymph node metastasis [in the current study, only 51 of 306 (17%) patients were diagnosed with lymph node metastasis], and with micrometastasis taken into account is now under investigation.
EMT have been found to contribute to invasion, metastatic dissemination and acquisition of therapeutic resistance of cancer cells [27] . Multiple different signaling pathways including nuclear factor kappa B, Wnt, transforming growth factor-b, Notch and Akt/GSK-3b/Snail have been reported regulating EMT [27] . In cervical cancer, gene expression arrays have identified an increase in the expression of the EMT-related genes (AKT and MMP3) in their lymph node micrometastases when compared with the primary tumors [28] ; Hsu et al. [29] reported KCC3 disrupted E-cadherin/b-catenin complex formation and promoted EMT in cervical cancer; Lee et al. [30] showed that epidermal growth factor cooperated with a 5 b 1 integrin signaling to induce EMT in cervical cancer cells via upregulated Snail. Recently, Valacca et al. [17] showed that Sam68 could regulate EMT through alternative splicing-activatednonsense-mediated decay of the SF2/ASF proto-oncogene mRNA in SW480 cells. Hence, we suppressed Sam68 expression by shRNA and demonstrated here, for the first time, that downregulation of Sam68 remarkably repressed cellular motility and invasion, and reversed EMT by inhibiting Akt/GSK-3b/Snail pathway.
Consistent with the findings obtained in this study, our previously reported findings suggest that cytoplasmic localization of Sam68 in human renal cell carcinoma and breast cancer may also have biological function [15, 16] . Given the fact that Sam68 could interact with PI3K through PI3K's SH2 domains [12] , and subcellular localization of Sam68 could be regulated by post-translational modifications, including phosphorylation and methylation [31, 32] ; taken together with our findings that down-regulation of Sam68 inhibited Akt/GSK-3b/Snail pathway, the possibility lies that in cervical cancer, Sam68 may be regulated by posttranslational modifications to localize in cytoplasmic space where Sam68 interacts with PI3K and induces lymph node metastasis through Akt/GSK-3b/Snail pathway-mediated EMT. Further research to validate this hypothesis, is underway. 
